News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The 2025 ESMO Lifetime Achievement Award Will Be Presented to Rolf A. Stahel – ETOP IBCSG Partners Foundation
Photo: internationalcancerfoundation.org
Aug 6, 2025, 08:30

The 2025 ESMO Lifetime Achievement Award Will Be Presented to Rolf A. Stahel – ETOP IBCSG Partners Foundation

ETOP IBCSG Partners Foundation shared a post on X:

“The 2025 ESMO Lifetime Achievement Award will be presented to Rolf A. Stahel at the ESMO 2025 Opening Ceremony.

Rolf  Stahel is President of our ETOP IBCSG Partners Foundation and a leading figure in thoracic oncology and cancer research.”

The 2025 ESMO Lifetime Achievement Award Will Be Presented to Rolf A. Stahel - ETOP IBCSG Partners Foundation

More posts featuring ETOP IBCSG Partners Foundation.

2025 ESMO Lifetime Achievement Award cancer ESMO Lifetime Achievement Award ETOP IBCSG Partners Foundation OncoDaily Oncology Rolf A. Stahel Rolf Stahel
Special Coverage
Insight
Aug 9, 2025, 15:47
Emad Shash: The First Detailed Look at Colorectal Cancer in Southern Egypt
Voices
Aug 9, 2025, 15:46
Martin Zapata Laguado: LOS2025 in São Paulo
Voices
Aug 9, 2025, 15:31
No Two Practices are the Same, and Neither are Their Approaches to Immunotherapy - NCODA
Stories
Aug 9, 2025, 15:19
1,000 Lives, One Message: Never Stop Caring - The Max Foundation
Voices
Aug 9, 2025, 15:05
Al-Ola Abdallah: Cross-Collaboration is Key for Cellular Therapies Options Across Cancer Types
Voices
Aug 9, 2025, 14:56
Are You Passionate About Patient Involvement in Cancer Research? - EORTC
Voices
Aug 9, 2025, 14:53
Aravind Palraj: Immune-Related Adverse Events Can Mimic Cancer Flare
Voices
Aug 9, 2025, 14:51
4 Days to Go Until the NSW Cancer Summit 2025 - Cancer Institute NSW
Societies
Aug 9, 2025, 13:59
AACR Project GENIE 18.0: Genomic Insights from 7,900+ Sarcoma and Bone Cancer Patients
Voices
Aug 9, 2025, 13:48
Nicola Normanno joins "From Policy to Practice" - EAPM
Oncolibrary
Aug 9, 2025, 12:50
FDA Grants Accelerated Approval to Zongertinib for HER2 TKD Mutated Non-Squamous NSCLC
Science
Aug 9, 2025, 12:08
Amol Akhade: Zongertinib - A New Targeted Therapy Option for a Rare Molecular Subset of Lung Cancer